VeriMomVeriMom
HIGH RISK

Sollte ich 3-benzylidene camphor in der Schwangerschaft meiden? | VeriMom

Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).

ECHA regulatory hazard statements

  • H361

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Ist 3-benzylidene camphor in der Schwangerschaft sicher?
Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
Ist 3-benzylidene camphor während des Stillens sicher?
Same hazard/mechanistic evidence applies (endocrine activity, SCCS concerns; ECHA SVHC listing). Topical cosmetic application can produce measurable systemic levels for lipophilic UV‑filter type compounds, so moderate exposure to the nursing parent (and potential low‑to‑moderate transfer to milk) is plausible though direct milk‑transfer data are lacking; therefore exposure scored as moderate (E=2).
Ist 3-benzylidene camphor sicher für Babyhaut?
Hazard and mechanism as above (SCCS: endocrine activity; ECHA: SVHC for endocrine disruption). Because infants 0–3 years have an immature skin barrier and higher surface‑area‑to‑body‑weight, exposure score is increased by +1 relative to adult topical exposure (adult E=2 → infant E=3). Infants may therefore be at higher internal exposure and greater sensitivity to hormonal perturbation.
Wie bewertet VeriMom 3-benzylidene camphor?
VeriMom bewertet 3-benzylidene camphor mit 13/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
Was sind schwangerschaftssichere Alternativen zu 3-benzylidene camphor?
Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu 3-benzylidene camphor basierend auf ähnlicher Funktion.

Prüfe jede Zutatenliste in 2 Sekunden

Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.

Medizinischer Haftungsausschluss

Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.

Erleben Sie VeriMom als App mit allen Funktionen